Primary Immunodeficiencies in Children Initially Admitted with Gastrointestinal/Liver Manifestations
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The gastrointestinal system is the most commonly affected organ, followed by the lungs, in patients with primary immunodeficiency disease (PID). Hence, it is common for children with PIDs to present with gastrointestinal symptoms. We aimed to analyze the clinical and histopathological findings of patients who were initially admitted to pediatric gastroenterology/hepatology clinics and subsequently diagnosed with PIDs to identify the clinical clues for PIDs. Methods: The demographic, laboratory, and histopathological findings, treatment modality, and outcomes of patients initially admitted to the pediatric gastroenterology/hepatology unit and subsequently diagnosed with PIDs were recorded. Results: The study included 24 patients (58.3% male; median age [range]: 29 [0.5–204] months). Common clinical presentations included chronic diarrhea (n=8), colitis (n=6), acute hepatitis (n=4), and acute liver failure (n=2). The association of autoimmune diseases, development of malignant diseases, and severe progression of viral diseases was observed in 20.8%, 8.3%, and 16.6% of the patients, respectively. Antibody deficiency was predominantly diagnosed in 29.2% of patients, combined immunodeficiency in 20.8%, immune dysregulation in 12.5%, defects in intrinsic and innate immunity in 4.2%, autoinflammatory disorders in 8.3%, and congenital defects of phagocytes in 4.2%. Five patients remained unclassified (20.8%). Conclusion: Patients with PIDs may initially experience gastrointestinal or liver problems. It is recommended that the association of autoimmune or malignant diseases or severe progression of viral diseases provide pediatric gastroenterologists some suspicion of PIDs. After screening using basic laboratory tests, genetic analysis is mandatory for a definitive diagnosis.
Abstract
Purpose: The gastrointestinal system is the most commonly affected organ, followed by the lungs, in patients with primary immunodeficiency disease (PID). Hence, it is common for children with PIDs to present with gastrointestinal symptoms. We aimed to analyze the clinical and histopathological findings of patients who were initially admitted to pediatric gastroenterology/hepatology clinics and subsequently diagnosed with PIDs to identify the clinical clues for PIDs. Methods: The demographic, laboratory, and histopathological findings, treatment modality, and outcomes of patients initially admitted to the pediatric gastroenterology/hepatology unit and subsequently diagnosed with PIDs were recorded. Results: The study included 24 patients (58.3% male; median age [range]: 29 [0.5–204] months). Common clinical presentations included chronic diarrhea (n=8), colitis (n=6), acute hepatitis (n=4), and acute liver failure (n=2). The association of autoimmune diseases, development of malignant diseases, and severe progression of viral diseases was observed in 20.8%, 8.3%, and 16.6% of the patients, respectively. Antibody deficiency was predominantly diagnosed in 29.2% of patients, combined immunodeficiency in 20.8%, immune dysregulation in 12.5%, defects in intrinsic and innate immunity in 4.2%, autoinflammatory disorders in 8.3%, and congenital defects of phagocytes in 4.2%. Five patients remained unclassified (20.8%). Conclusion: Patients with PIDs may initially experience gastrointestinal or liver problems. It is recommended that the association of autoimmune or malignant diseases or severe progression of viral diseases provide pediatric gastroenterologists some suspicion of PIDs. After screening using basic laboratory tests, genetic analysis is mandatory for a definitive diagnosis.
참고문헌 (33)
- Raje N, "Overview of immunodeficiency disorders", Immunol Allergy Clin North Am, 35, pp.599~623 (2015)
- Bousfiha A, "Human inborn errors of immunity : 2019 update of the IUIS phenotypical classification", J Clin Immunol, 40, pp.66~81 (2020)
- Hartono S, "Gastrointestinal disorders associated with primary immunodeficiency diseases", Clin Rev Allergy Immunol, 57, pp.145~165 (2019)
- Rodrigues F, "Liver disease in children with primary immunodeficiencies", J Pediatr, 145, pp.333~339 (2004)
- Hadzic N, "Concise Pediatric and Adolescent Hepatology", pp.64~75 (2012), Karger
- "Working definitions for clinical diagnosis of PID" (2019)[URL]
- Aksu G, "Serum immunoglobulin(IgG, IgM, IgA)and IgG subclass concentrations in healthy children : a study using nephelometric technique", Turk J Pediatr, 48, pp.19~24 (2006)
- Jessurun J, "The differential diagnosis of acute colitis : clues to a specific diagnosis", Surg Pathol Clin, 10, pp.863~885 (2017)
- Guerrerio AL, "Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases", J Pediatr Gastroenterol Nutr, 51, pp.548~555 (2010)
- Schwimmer D, "Primary immunodeficiency and the gut", Gastroenterol Clin North Am, 48, pp.199~220 (2019)
- Lee WI, "A nationwide study of severe and protracted diarrhoea in patients with primary immunodeficiency diseases", Sci Rep, 7, pp.3669~ (2017)
- Malesza IJ, "Primary humoral immune deficiencies : overlooked mimickers of chronic immune-mediated gastrointestinal diseases in adults", Int J Mol Sci, 21, pp.5223~ (2020)
- Bourgeois P, "THES clinical consortium. Tricho-Hepato-Enteric Syndrome mutation update: mutations spectrum of TTC37 and SKIV2L, clinical analysis and future prospects", Hum Mutat, 39, pp.774~789 (2018)
- Jamee M, "Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, x-linked(IPEX)and IPEX-like syndrome", J Allergy Clin Immunol Pract, 8, pp.2747~2760 (2020)[DOI]
- Pagel J, "Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5(FHL5)", Blood, 119, pp.6016~6024 (2012)
- Reynolds S, "Successful management of Barth syndrome : a systematic review highlighting the importance of a flexible and multidisciplinary approach", J Multidiscip Healthc, 8, pp.345~358 (2015)
- Ge T, "Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, x-Linked syndrome with intractable diarrhea : a case report", Front Pediatr, 5, pp.267~ (2017)
- Kelsen JR, "Inflammatory bowel disease in primary immunodeficiencies", Curr Allergy Asthma Rep, 17, pp.57~ (2017)
- Tegtmeyer D, "Inflammatory bowel disease caused by primary immunodeficiencies-Clinical presentations, review of literature, and proposal of a rational diagnostic algorithm", Pediatr Allergy Immunol, 28, pp.412~429 (2017)
- Uhlig HH, "COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease", Gastroenterology, 147, pp.990~1007 (2014)
- Akkelle BS, "Gastrointestinal manifestations in children with primary immunodeficiencies : single center : 12 years experience", Dig Dis, 37, pp.45~52 (2019)
- Takagi M, "Haploinsufficiency of TNFAIP3(A20)by germline mutation is involved in autoimmune lymphoproliferative syndrome", J Allergy Clin Immunol, 139, pp.1914~1922 (2017)
- Rai T, "Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease", Gastroenterol Rep(Oxf), 3, pp.115~121 (2015)
- Yorulmaz A, "Evaluation of patient follow-up with transient hypogammaglobulinemia in infancy diagnosis", J Contemp Med, 9, pp.15~20 (2019)
- Karaca NE, "New laboratory findings in Turkish patientswith transient hypogammaglobulinemia of infancy", Iran J Allergy Asthma Immunol, 9, pp.237~243 (2010)
- Bezrodnik L, "Hypogammaglobulinaemia secondary to cow-milk allergy in children under 2 years of age", Immunology, 122, pp.140~146 (2007)
- Fiore M, "Chronic unexplained liver disease in children with primary immunodeficiency syndromes", J Clin Gastroenterol, 26, pp.187~192 (1998)
- Hanna S, "MHC class I and II deficiencies", J Allergy Clin Immunol, 134, pp.269~275 (2014)
- Odineal DD, "The epidemiology and clinical manifestations of autoimmunity in selective IgA deficiency", Clin Rev Allergy Immunol, 58, pp.107~133 (2020)
- Gaspar HB, "X-linked lymphoproliferative disease : clinical, diagnostic and molecular perspective", Br J Haematol, 119, pp.585~595 (2002)
- Khoreva A, "Complex multisystem phenotype with immunodeficiency associated with NBAS mutations : peports of three patients and review of the literature", Front Pediatr, 8, pp.577~ (2020)
- Szabo G, "Inflammasomes in liver diseases", J Hepatol, 57, pp.642~654 (2012)
- Cunniff C, "Bloom’s syndrome : clinical spectrum, molecular pathogenesis, and cancer oredisposition", Mol Syndromol, 8, pp.4~23 (2017)